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Non‑communicable diseases (NCDs) are an increasing problem worldwide, including in Malaysia. 
National surveys have been performed by the government but had poor coverage in east Malaysia, 
particularly in rural regions. This study aimed to describe the achievement of target therapeutic 
outcomes in the control of diabetes mellitus (DM), hypertension (HPT), and dyslipidemia (DLP) among 
diabetic patients in rural east Malaysia. A cross‑sectional study was conducted among DM patients 
who visited the NCDs clinic in Lundu Hospital, Sarawak, Malaysia, from Jan to March 2016. In total, 
214 patients (male, 37.9%; female, 62.1%) were recruited using a systemic sampling method. Multiple 
logistic regression models were applied to estimate the adjusted odds ratio (AOR) and confidence 
interval (CI) for the target therapeutic achievement in the control of DM, HPT, and DLP. Compared to 
the national average, therapeutic target achievement in Lundu was higher for DM (43.0% vs. 23.8%), 
equal for DLP (35.8% vs. 37.8%) but lower for HPT (30.9% vs. 47.9%). DM patients who had at least 
yearly HbA1c monitoring (AOR 2.30, 95% CI 1.04–5.06, P = 0.039), and those 58.7 years or older (AOR 
2.50, 95% CI 1.32–4.74, P = 0.005) were more likely to achieve the therapeutic target for DM. Health 
promotion and public education regarding HPT needs to be emphasized in rural Malaysia. HbA1c 
monitoring at least once a year was one of the important factors associated with achieving DM control 
in rural east Malaysia. Accessibility to HbA1c tests and monitoring should be ensured for diabetic 
patients.
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Non-communicable diseases (NCDs) are an increasing problem worldwide, including in Malaysia. The World 
Health Organization (WHO) reported that 71% of all deaths in 2018 were due to NCDs. Of these, cardiovascular 
diseases alone accounted for 44% of all NCDs  deaths1. With rising population and prevalence for NCDs, health 
expenditures have been increasing  globally2. Cost savings and the sustainability of the health system are major 
issues in nations that aim to achieve universal health coverage, thus, prevention and good control of NCDs have 
been shown to be the most economical way to manage the  problem3. Malaysia government provides highly 
subsidised healthcare for all Malaysian and had achieved universal health coverage (UHC) in 1990’s4. As a tax 
funded national healthcare system  however4, providing good quality and accessibility while managing cost is 
always a challenge.
Malaysia has seen a shift in the causes of mortality through the years. In 2007, for the first time, diseases of 
the circulatory system overtook infectious diseases as the number one cause of mortality in hospital settings and 
have continued to increase as a proportion of the total  mortality5. The latest Ministry of Health Annual Report 
indicated a consistent disproportionate increase in nephrology and cardiology cases seen in specialist clinic from 
2002 to 2011, increasing from 0.85% to 2.41% for nephrology and 1.01% to 4.58% for cardiology of all cases, 
both of which are highly dependent on the management of NCDs in the  country6,7. The 5th National Health 
and Morbidity Survey (NHMS), performed in Malaysia in 2015, also reported that 17.5%, 30.3%, and 47.7% of 
adults have diabetes mellitus (DM), hypertension (HPT), and dyslipidemia (DLP), respectively, in Malaysia, a 
persistent increase since the first survey was conducted in  19868,9.
Preventive health leads to an improvement of general public health, prevents overcrowding of tertiary cent-
ers, and reduces the long-term cost of  healthcare10. Studies of NCDs have been conducted in Malaysia, although 
often concentrated only in west Malaysia and urban  areas11. DiabCare 2013 was a multi-center study carried out 
to gauge the control of NCDs in DM patients in both east and west Malaysia; however, it was only performed 
in urban, tertiary  centers12.
The rural population in Malaysia has been reducing through the years, but still made up 25% of the general 
population in  201713. Rural regions are frequently plagued with infrastructure and resources restrictions thus 
may consist of a different pattern of control for NCDs compared to the urban region. However, information 
regarding rural primary healthcare centers’ achievements in NCDs are scarce.
To the best of our knowledge, factors affecting HbA1c achievement have been reported in studies in Malaysia 
but never in rural east Malaysia, where indigenous populations are  predominant14. In addition, demography 
background such as the relationship between biochemical monitoring such as HbA1c and fasting lipid profile 
(FLP) to DM and DLP control have never been examined. The National Diabetes Registry Report (NDR) 2012 
reported that up to 22.0% of diabetic patients managed in government clinics did not undergo any HbA1c 
monitoring in a  year15. The ratio of HbA1c monitoring varies significantly between states, and is likely worse in 
east Malaysia, where many health facilities are not equipped with HbA1c-capable laboratories. Thus, this study 
aimed to examine the associations of the target therapeutic achievement in the three diseases with age, years of 
follow-up, sex, ethnicity, body mass index (BMI), smoking status, and relevant biochemical monitoring, and to 
describe the control of DM, HPT, and DLP in a rural setting in east Malaysia, bridging the gap of information 
available in Malaysia to assist policymakers in creating more effective long-term nationwide plans catering to 
both east and west Malaysia as well as urban and rural populations.
Materials and methods
Study design and participants. A cross-sectional study was conducted in Lundu District Hospital, in the 
northwest Kuching Division of Sarawak, east Malaysia. The population of Lundu constitutes 1.4% (33,413) of the 
total population of Sarawak. As comparison, the similarly sized neighbouring urban Kuching District have close 
to 19 times the number of  population16. Lundu District population, like the rest of less developed Sarawak, gen-
erally engaged in agriculture, aquaculture, fishing as well as tourism as main economical  activities16. The latest 
official document in 2010 combines both indigenous populations (mainly Bidayuh and Iban) and Malays in the 
statistics, making up 82.4% of the total population, while the Chinese population constitutes another 10.6%17. 
Besides an adequately maintained single carriageway dual lane highway connecting Lundu to other District, 
roads connecting to smaller villages in Lundu are mostly single lane, unpaved road, with wooden bridges con-
necting between multiple rivers running across the district, making even intra-district traveling challenging and 
time consuming.
Lundu Hospital offers both inpatient and outpatient services and is the sole healthcare center in the Lundu 
District. The hospital is a 40 bedded hospital with average of close to 130 outpatient visits per day. A DM patient 
is initially diagnosed in the outpatient clinic by a doctor and sent to register with the NCDs division under the 
outpatient department situated inside Lundu Hospital for further regular follow-ups. The patients’ history and 
treatment information are recorded in two places: 1) a record book given to patients to be brought around, if 
needed; 2) an identical diabetes registry record kept in the NCDs clinic as a precaution against lost information. 
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Both records should receive identical input from the doctor upon follow-up, but due to errors and negligence, 
at times only one record receives the input.
Owing to the weaknesses mentioned above, this study was conducted by identifying patients and obtaining 
their record card during their follow-ups instead of merely extracting information from the diabetes registry 
record as it allowed investigators to extract and synchronize information from both the record book and the 
diabetes registry record. Furthermore, the total diabetes registry record in the clinic was numbered at 1048; 
however, it dates back to 1992 and was never updated. The 1048 records included many patients who had moved, 
died, or defaulted completely.
As the patient’s visit interval to the clinic may vary, to recruit based on the attendance of the patient, we 
needed to remove the duplicates while not excluding patients with longer follow-ups. The follow-up duration that 
was given to any diabetic patient in this clinic was between 1 week and 3 months; thus, 3 months was chosen as 
the duration of our study. Based on information from September 2015 to November 2015, we found that there 
was an average of 440 unique visits in a total of 1074 visits in 3 month, and based on our estimation, a recruitment 
of roughly every 5–6 patients would have been sufficient for our sample size requirement of 205 (based on 440 
unique visits). In the end, we decided to recruit the first and then every 6th patient after who visited the NCDs 
clinic in Lundu Hospital, from every weekday from January 1 to March 30, 2016, synchronizing information 
from both record books of patients and diabetes registry records.
Inclusion criteria were as follows: patients older than 18 years, diagnosed as having Type 2 DM, not pregnant, 
and followed up for at least 1 year in the NCDs clinic. A total of 260 patients were recruited. Among them, 33 
patients were found to be duplicated, 10 of them had only been followed up for less than 1 year in the NCDs 
clinic, and three had been transferred from other NCDs clinics, with poor documentation. Therefore, a final total 
of 214 were considered for further data analysis. Three qualified medical doctors who were also the investigators 
of this study were involved in the digitalization of the diabetes registry records. A digital data form is created 
for each entry with necessary information required to be filled in in order to proceed to prevent incomplete 
data collection.
Data collection. Data collection was performed by retrieving data from the diabetes registry record and 
the patient’s record book. The first page of the records containing information regarding initial registration in 
the NCDs clinic, demographics, medical history, risk factors, the year of diagnosis, and BMI were obtained. The 
latest visit with documentation of BMI, biochemical results, and last date of biochemical tests were obtained.
Therapeutic target achievements. Therapeutic target achievements for the three NCDs (DM, HPT, and 
DLP) were defined similarly to the latest national data, namely the National Diabetes Registry Report 2012 
(NDR), defining a single target therapeutic range for DM, HPT, and DLP. The target therapeutic range for DM 
was defined as 6.5% or below, HPT was defined as ≤ 130 mmHg/90 mmHg and DLP target as low-density lipo-
protein cholesterol (LDL-C) ≤ 2.6  mmol/L15. The target biochemical examination regular interval for HbA1c 
was ≤ 12 months18, while that of FLP was defined as ≤ 6 months19, following the latest Malaysian clinical practice 
guidelines during the conduction of the research.
Statistical analysis. The collected data were analyzed using the Statistical Package for Social Science (SPSS 
for Windows program version 25; IBM, Armonk, New York, USA). Descriptive statistics were calculated for 
demographic information, therapeutic target achievement, and biochemical examination interval. The data 
obtained were further classified into dichotomous factors. Three separate logistic regression models were used to 
measure the odds ratio (OR) of the achievement of therapeutic control targets for DM, HPT, and DLP. A P-value 
of less than 0.05 was considered significant.
Ethical considerations. This study protocol was approved by Medical Research and Ethics Committee 
(MREC) of the National Medical Research Register (NMRR) (approval number NMRR-14-1867-23844, issued 
on October 19, 2015). All methods were performed in accordance with the relevant guidelines and regulations. 
Permission to conduct the research in Hospital Lundu was given by MREC and director of Hospital Lundu. 
The requirement for informed written consent from each participant was waived by MREC, as this study only 
included information from existing medical records and do not involve interaction with patient or collection 
of identifiable private information. Each entry of sample data was assigned an identification number in place of 
names to ensure confidentiality.
Results
Table 1 indicates the sociodemographic characteristics of the 214 patients. In total, 81 (37.9%) men and 133 
(62.1%) women were included. The duration of follow-up in the NCDs clinic ranged from 1 to 33 years. The par-
ticipants’ mean age was 58.7 (standard deviation [SD], 12.1). The greatest proportion (35.5%) of patients belonged 
to the Malay ethnicity, followed by Bidayuh at 26.6% and Iban at 19.6%. After combining different ethnicity into 
indigenous and non-indigenous people, 46.2% of the participants were grouped as indigenous populations. This 
study found that 87.9% of the patients had HPT, 70.6% had DLP, and 62.6% had all three diseases (DM, HPT, 
and DLP). Male smokers outnumbered female smokers by more than 10 times (25.9% vs. 1.5%). There were five 
patients (2.3%) with peripheral artery disease, four patients (1.9%) with coronary heart disease, three patients 
(1.4%) with cerebrovascular accidents, and two patients (0.9%) with renal failure. For biochemical monitoring, 
81.3% of the patients had HbA1c performed yearly and 74.3% had semiannual FLP.
Table 2 describes the therapeutic target achievement for DM, HPT, and DLP. Table 3 describes the binary 
logistic regression analyses for the therapeutic target achievement for DM and DLP after adjustment.
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Diabetes mellitus. The proportion of patients achieving the HbA1c target was 43.0% in this study, with a 
mean HbA1c of 7.7% and mean follow-up duration of 8.4 years (Table 2). Age (unadjusted odds ratio [UOR] 
2.06, 95% confidence interval [CI] 1.19–3.56, P < 0.01), BMI (UOR 2.16, 95% CI 1.14–4.08, P < 0.05), and HbA1c 
yearly monitoring (UOR 2.30, 95% CI 1.08–4.89, P < 0.05) were found to have significant effects on achiev-
ing target therapy control for DM. Other factors such as sex, ethnicity, smoking habit, duration of follow-up, 
and FLP monitoring were not significantly associated with achievement of target therapy control for DM. DM 
patients with HbA1c yearly monitoring (adjusted odds ratio [AOR] 2.30, 95% CI 1.04–5.06, P < 0.05), age ≥ 58.7 
(AOR 2.50, 95% CI 1.32–4.74, P < 0.01), and duration of DM follow–up < 8.4 years (AOR 2.58, 95% CI 1.35.4.96, 
P < 0.01) remained significant after adjusting for age, sex, ethnicity, current smoking habit, BMI, duration of DM 
follow-up, and HbA1c yearly monitoring.
Table 1.  Sociodemographic characteristics of patients (N = 214).
Characteristics
Male Female Total
N (%) N (%) N (%)
Total 81 (37.9) 133 (62.1) 214 (100.0)
Age
21–40 5 (6.2) 4 (3.0) 9 (4.2)
41–60 48 (59.3) 74 (55.6) 122 (57.0)
61–80 24 (29.6) 52 (39.1) 76 (35.5)
> 80 4 (4.9) 3 (2.3) 7 (3.3)
Ethnicity
Indigenous population (46.3)
Bidayuh 26 (32.1) 31 (23.3) 57 (26.7)
Iban 18 (22.2) 24 (18.0) 42 (19.6)
Non-Indigenous population (53.7)
Malay 21 (25.9) 55 (41.4) 76 (35.5)
Chinese 15 (18.5) 21 (15.8) 36 (16.8)
Indian 1 (1.3) 2 (1.5) 3 (1.4)
Currently smoking
No 60 (74.1) 131 (98.5) 191 (89.3)
Yes 21 (25.9) 2 (1.5) 23 (10.7)
BMI (kg/m2)
< 30 59 (72.8) 95 (71.4) 154 (72.0)
≥ 30 22 (27.2) 38 (28.6) 60 (28.0)
Comorbidities
HPT 69 (85.2) 119 (89.5) 188 (87.9)
DLP 58 (71.6) 93 (69.9) 151 (70.6)
All 3 diseases 50 (61.7) 84 (63.2) 134 (62.6)
Biochemical monitoring
HbA1c yearly 62 (76.5) 112 (84.2) 174 (81.3)
Less frequent than yearly 19 (23.5) 21 (15.8) 40 (18.7)
FLP 6 monthly 59 (72.8) 100 (75.2) 159 (74.3)
Less frequent than 6 monthly 22 (27.2) 33 (24.8) 55 (25.7)




DM 214 92 (43.0)
National DM average in 2012 (23.8)
HPT 188 58 (30.9)
National HPT average in 2012 (47.6)
DLP 151 54 (35.8)
National DLP average in 2012 (37.8)
Two or more diseases 205 63 (30.7)
All three diseases 134 9 (6.7)
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Hypertension. The proportion of patients with HPT in this study was 87.9% (N = 188), with a mean age 
of 60.4 years and follow-up duration of 10.5 years. Mean systolic BP was 138.5 mmHg and diastolic BP was 
75.6 mmHg. Therapeutic target achievement for HPT in diabetic patients was 30.9% (Table 2).
None of the factors were found to be significantly associated with HPT therapeutic target achievement before 
as well as after adjustments for age, sex, ethnicity, smoker, BMI, and duration of HPT follow-up.
Dyslipidemia. The proportion of patients with DLP was 70.6% (N = 151), with a mean age of 58.8 years and 
a follow-up duration of 5.8 years. The means of the lipid profile for total cholesterol (TC), triglyceride (TG), 
high-density lipoprotein cholesterol (HDL-C), and LDL-C were 4.99 mmol/L, 2.15 mmol/L, 1.27 mmol/L, and 
2.80 mmol/L, respectively. Therapeutic target achievement for DLP in diabetic patients was 35.8% (Table 2).
For DLP, indigenous population ethnicity (UOR 3.01, 95% CI 1.45–6.21, P < 0.01) and BMI < 30 (UOR 3.03, 
95% CI 1.23–7.45, P < 0.05) were found to be positively associated with DLP therapeutic target achievement. 
Indigenous population ethnicity (AOR 2.31, 95% CI 1.04–5.12, P < 0.05) and BMI < 30 (AOR 3.32, 95% CI 
1.15–9.58, P < 0.05) continued to be significant factors for DLP therapeutic target achievement after adjustments 
for age, sex, ethnicity, smoker, BMI, duration of DLP follow-up, and FLP monitoring (Table 3).
Two diseases. The proportion of patient with at least two NCD was 95.8% (N = 205). In this group of patient, 
30.7% have at least two NCD achieving target therapeutic level.
All three diseases. The proportion of patients with all three diseases was 62.6% (N = 134), with a mean age 
of 60.2 years and follow-up duration of 6.2 years.
For patients with all three diseases, only 6.7% achieved the therapeutic targets for all three diseases. No cur-
rent smoker found in this group. No significant factors affecting therapeutic targets for all three diseases were 
found. However, after adjusting for age, sex, ethnicity, BMI, duration of follow-up, HbA1c yearly monitoring, 
and FLP monitoring, male sex (AOR 4.26, 95% CI 1.06–17.05, P < 0.05) showed an association with therapeutic 
target achievement four times higher than in females (Table 3).
Discussion
This study is one of the first to highlight target therapeutic control achievement for DM as well as HPT and DLP 
control in diabetic patients among the indigenous population ethnicities of rural east Malaysia. The control of 
DM and DLP in diabetic patients was found to be at least equal or better in rural areas in Malaysia at the national 
Table 3.  Adjusted odds ratio (AOR) and 95% confidence interval (CI) of factors for therapeutic target 
achievement. *P < 0.05; **P < 0.01.
Characteristic
DM DLP All
AOR (95% CI) AOR (95% CI) AOR (95% CI)
Sex
Female 1 (reference) 1 (reference) 1 (reference)
Male 0.87 (0.46–1.68) 1.68 (0.70–4.05) 4.26 (1.06–17.05)*
Age
< Mean years 1 (reference) 1 (reference) 1 (reference)
≥ Mean years 2.50 (1.32–4.74)** 1.63 (0.70–3.81) 4.50 (0.93–21.73)
Ethnicity
Non-indigenous population 1 (reference) 1 (reference) 1 (reference)
Indigenous population 1.31 (0.73–2.38) 2.31 (1.04–5.12)* 1.99 (0.50–7.86)
Smoking habit
Non-smoker 1 (reference) 1 (reference) 1 (reference)
Smoker 1.03 (0.38–2.83) 0.74 (0.21–2.62) –
Duration of follow-up
 ≥ Mean years 1 (reference) 1 (reference) 1 (reference)
 < Mean years 2.58 (1.35–4.96)** 0.50 (0.21–1.17) 2.94 (0.53–16.32)
BMI
 ≥ 30 1 (reference) 1 (reference) 1 (reference)
 < 30 1.96 (0.98–3.91) 3.32 (1.15–9.58)* 1.30 (0.23–7.38)
HbA1c monitoring
Not yearly 1 (reference) 1 (reference) 1 ( reference  reference)
At least yearly 2.30 (1.04–5.06)* – 1.52 (0.13–17.23)
FLP monitoring
Not every 6 months 1 (reference) 1 (reference) 1 (reference)
At least 6 monthly – 0.9 (0.35–2.31) 1.21 (0.19–7.71)
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level; however, control of HPT was worse. Those receiving HbA1c yearly monitoring were twice as likely to meet 
the target therapeutic achievement for DM.
Good diabetic control has favorable long-term macrovascular and microvascular  outcomes20. In this study, 
HbA1c yearly monitoring was performed in 81.3% of patients, who were found to be twice as likely to achieve 
therapeutic targets of DM. We can only speculate that the association may be due to good vigilance and attention 
given to the disease by both the patient and healthcare provider. First, the general compliance of the patient; 
they did not miss the scheduled follow-ups so that HbA1c tests could be performed. Second, the HbA1c result 
assisted the doctor in recognizing the patient’s average control over the past 3 months, rather than relying on the 
fasting blood sugar that varies highly based on the activity of the patient in the past few hours. Both factors lead 
to better treatment compliance and an improved response to changes in the disease. Given its straightforward 
implementation of making such tests available to perform, the government should consider tightly enforcing 
yearly HbA1c monitoring to ensure better diabetic control outcomes.
Moreover, older age and shorter duration of DM were found to be two times more likely to contribute to 
achieving diabetic control. This is in contrast with the common idea that older age is associated with non-
adherence to medication, due to factors such as isolation and cost-related non-adherence21,22. However, with 
Malaysia being a family centric culture and medical care being provided practically free of cost, older age may 
not lead to the same problems found in other countries. The finding of shorter durations of disease leading to 
better control of DM, on the other hand, was expected and corresponded well with the fact that diabetic control 
worsens over  time23.
DM is known to be an independent risk factor for cardiovascular  diseases24, and DM itself was found to 
have a magnifying effect on cardiovascular risk for other risk factors, such as DLP and  HPT25. The mortality of 
diabetic patients also tends to be higher for coronary  diseases26, making control of HPT and DLP in diabetic 
patients important. DLP control was found to be three times greater with BMI < 30 and two times greater among 
indigenous population ethnicities. The relationship between BMI and DLP has been studied  extensively27, while 
the association between ethnicity and DLP control is unclear. A previous study from Malaysia reported that 
indigenous population Sarawakians had similar metabolic syndrome prevalence as other ethnicities, although 
the components of the metabolic syndrome were numerous, and a specific identification could not be  made28. 
Although another study found that east Malaysians engage in lesser physical activity than Malays and Chinese, 
the ethnicities were not grouped further in the east Malaysian  sample29. In the same study, however, higher 
physical activity was found to be associated with rural communities, which may partially explain the better DLP 
control in the indigenous population group in this  study29.
A dedicated description of DM, HPT, and DLP control in diabetic patients in rural east Malaysia was not 
previously available. Using the same targets as the NDR, this study found the DM and DLP control of diabetic 
patients in Lundu to be at least equal to national levels but was poor for HPT control. The target achievement of 
HbA1c at 6.5% or lower was 43.0%, which was significantly higher than the national level of 23.8% and any of 
the West Malaysian states (14.9–31.1%)15, as well as that of the Sarawak State as a whole, 39.1%15. The control of 
DLP in our study was 35.8%, roughly equal to 37.8% in the  NDR15, while the target blood pressure achieved in 
our study was 30.9%, which is lower than the national mean of 47.6% in  201215. A major difference between the 
figures for Lundu and the national figures may be due to the predominant indigenous population demographic 
in Lundu. Indigenous populations were traditionally rice farmers/fishermen, and those who remain in rural 
areas mostly still engage in physically demanding agricultural  work30, and hence indirectly lead a healthier 
lifestyle. A study from Saudi Arabia supports the findings of this study, noting that rural regions are associated 
with better control of DM than urban  regions31. The finding of worse HPT control in rural areas also reinforces 
the findings of a study in west Malaysia, which found that membership in the rural population is a risk factor 
for poor control of  HPT32. A higher emphasis should be placed on HPT during health promotion activities and 
education programs in rural Malaysia.
As for the two-thirds of patient having all three diseases in this study, it was found that male sex was associ-
ated with achieving good control of all three diseases. Sex-specific pathophysiological differences in metabolic 
syndromes of which DM, HPT, and DLP were part of have been  documented33, but direct link with control in 
terms of target therapeutic achievement has not been established. Also, we speculate that influenced by a more 
traditional male-dominant family and society in the rural area where resources are limited, a more frequent 
healthcare appointment to optimise control of multiple comorbidities may be out of reach for some females. 
A bigger study focusing on sociodemographic, sex and compliance to follow-up is needed to fully explore the 
association.
The results of this study provide suggestions for future research directions. This study found that indigenous 
population ethnicity was significant in controlling DLP, perhaps due to a genetic predisposition or cultural 
lifestyle, suggesting that future research that includes east Malaysians should consider ethnicity as a factor in 
the analysis.
There are limitations to this cross-sectional study. Other important sociodemographic factors such as educa-
tion level, income, and distance from healthcare centers were not included in this study. The target population 
was limited to patients with DM. The sampling method may have indirectly excluded patients with poor diabetic 
control, as patients who defaulted treatment for more than 3 months would not be included in the sampling 
period. This study was conducted only in one of the twenty-eight rural districts in Sarawak, east Malaysia.
Conclusions
In conclusion, this study revealed that rural east Malaysia may experience a different pattern of NCDs control 
when compared to the rest of Malaysia. This provides useful data for local healthcare officials to plan health 
promotion strategies. Ensuring HbA1c monitoring may be a useful tool in achieving target therapy control 
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for DM. Accessibility to laboratory tests and enforcement of HbA1c monitoring in diabetic patients must be 
ensured in all healthcare centers for better control of diabetes. The patients’ ethnicity needs to be considered 
while examining dyslipidemia in east Malaysia.
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